LineLabelWBD-PValueSourceMessage
1Dimensions period from 2001-01-01 to 2001-12-31 for SAMP Scenario-1
2U-Monetary
3company:By Product (Placeholder)//company:All Products
4company:Sales[..., company:By Region (Placeholder)//company:All Regions]  INF32,465,000bothOK
5company:Sales[..., company:By Region (Placeholder)//company:US and Canada Region]1 INF10,137,000inst 
6company:Sales[..., company:By Region (Placeholder)//company:Europe Region]1 INF10,396,000inst 
7company:Sales[..., company:By Region (Placeholder)//company:Asia Region]1 INF3,210,000inst 
8company:Sales[..., company:By Region (Placeholder)//company:Other Regions]1 INF8,722,000inst 
 
9company:By Region (Placeholder)//company:All Regions
10company:Sales[..., company:By Product (Placeholder)//company:All Products]  INF32,465,000bothOK
11company:Sales[..., company:By Product (Placeholder)//company:Pharmaceuticals Segment]1 INF15,275,000inst 
12company:Sales[..., company:By Product (Placeholder)//company:Consumer Health Segment]1 INF5,752,000inst 
13company:Sales[..., company:By Product (Placeholder)//company:Generics Segment]1 INF1,823,000inst 
14company:Sales[..., company:By Product (Placeholder)//company:Other Segments]1 INF9,615,000inst 
 
15Dimensions period from 2002-01-01 to 2002-12-31 for SAMP Scenario-1
16U-Monetary
17company:By Product (Placeholder)//company:All Products
18company:Sales[..., company:By Region (Placeholder)//company:All Regions]  INF35,805,000bothOK
19company:Sales[..., company:By Region (Placeholder)//company:US and Canada Region]1 INF12,649,000inst 
20company:Sales[..., company:By Region (Placeholder)//company:Europe Region]1 INF10,374,000inst 
21company:Sales[..., company:By Region (Placeholder)//company:Asia Region]1 INF4,371,000inst 
22company:Sales[..., company:By Region (Placeholder)//company:Other Regions]1 INF8,411,000inst 
 
23company:By Region (Placeholder)//company:All Regions
24company:Sales[..., company:By Product (Placeholder)//company:All Products]  INF35,805,000bothOK
25company:Sales[..., company:By Product (Placeholder)//company:Pharmaceuticals Segment]1 INF18,150,000inst 
26company:Sales[..., company:By Product (Placeholder)//company:Consumer Health Segment]1 INF6,514,000inst 
27company:Sales[..., company:By Product (Placeholder)//company:Generics Segment]1 INF1,973,000inst 
28company:Sales[..., company:By Product (Placeholder)//company:Other Segments]1 INF9,168,000inst 
 
29Dimensions period from 2003-01-01 to 2003-12-31 for SAMP Scenario-1
30U-Monetary
31company:By Product (Placeholder)//company:All Products
32company:Sales[..., company:By Region (Placeholder)//company:All Regions]  INF32,038,000bothOK
33company:Sales[..., company:By Region (Placeholder)//company:US and Canada Region]1 INF10,214,000inst 
34company:Sales[..., company:By Region (Placeholder)//company:Europe Region]1 INF11,901,000inst 
35company:Sales[..., company:By Region (Placeholder)//company:Asia Region]1 INF5,639,000inst 
36company:Sales[..., company:By Region (Placeholder)//company:Other Regions]1 INF4,284,000inst 
 
37company:By Region (Placeholder)//company:All Regions
38company:Sales[..., company:By Product (Placeholder)//company:All Products]  INF32,038,000bothOK
39company:Sales[..., company:By Product (Placeholder)//company:Pharmaceuticals Segment]1 INF20,181,000inst 
40company:Sales[..., company:By Product (Placeholder)//company:Consumer Health Segment]1 INF6,675,000inst 
41company:Sales[..., company:By Product (Placeholder)//company:Generics Segment]1 INF2,433,000inst 
42company:Sales[..., company:By Product (Placeholder)//company:Other Segments]1 INF2,749,000inst 


Contexts
IDD-2003-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2002-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2001-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2003-Pharm
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Pharmaceuticals Segment
 
IDD-2002-Pharm
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Pharmaceuticals Segment
 
IDD-2001-Pharm
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Pharmaceuticals Segment
 
IDD-2003-Gen
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Generics Segment
 
IDD-2002-Gen
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Generics Segment
 
IDD-2001-Gen
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Generics Segment
 
IDD-2003-ConHealth
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Consumer Health Segment
 
IDD-2002-ConHealth
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Consumer Health Segment
 
IDD-2001-ConHealth
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Consumer Health Segment
 
IDD-2003-OtherSeg
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Other Segments
 
IDD-2002-OtherSeg
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Other Segments
 
IDD-2001-OtherSeg
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//company:All Regions
Scenariocompany:By Product (Placeholder)//company:Other Segments
 
IDD-2003-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//company:US and Canada Region
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2002-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//company:US and Canada Region
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2001-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//company:US and Canada Region
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2003-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//company:Europe Region
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2002-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//company:Europe Region
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2001-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//company:Europe Region
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2003-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//company:Asia Region
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2002-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//company:Asia Region
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2001-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//company:Asia Region
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2003-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//company:Other Regions
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2002-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//company:Other Regions
Scenariocompany:By Product (Placeholder)//company:All Products
 
IDD-2001-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//company:Other Regions
Scenariocompany:By Product (Placeholder)//company:All Products


Extended Links
ID
RoleDefault Link [http://www.xbrl.org/2003/role/link]

Units
IDU-Monetary
Measure<measure>iso4217:EUR</measure>

Performance Statistics
(seconds)
DTS grammars cached0
XML Validation0.0400576
Numeric context period checks0
Build calculation tree graph0
Evaluate formula dependency0
Evaluate required and essence-aliased facts0.0300432
Calculation tree roll-ups pass 10
Independent formula execution 0
Begin dimension rollup validation0
... Sales roll-ups pass 10.1101584
Update displayed instance0
Finish0

Product version: 6.403.2221.19361 (2006-01-30 11:45)

Software and look and feel © 2002-2006
Universal Business Matrix, inc (UBmatrix)
803 Kirkland Avenue, Suite 200
Kirkland, Washington, USA 98033-6318